Effects of everolimus (EVE) on disease progression in bone and bone markers (BM) in patients (pts) with bone metastases (mets). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gnant, Michael
  • Baselga, Jose
  • Rugo, Hope S
  • Noguchi, Shinzaburo
  • Pritchard, Kathleen
  • Burris, Howard A
  • Piccart-Gebhart, Martine J
  • Hart, Lowell L
  • Eakle, Janice F
  • Mukai, Hirofumi
  • Iwata, Hiroji
  • El-Hashimy, Mona
  • Rao, Shantha
  • Taran, Tanya
  • Sahmoud, Tarek
  • Lebwohl, David Edward
  • Hortobagyi, Gabriel N

publication date

  • May 20, 2012